Active — Not RecruitingNot Applicable

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

United States120 participantsStarted 2023-07-01

Plain-language summary

The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Caregiver Inclusion Criteria: * Adult caregivers (\>18 years) who is a relative or friend who live with the patient or is a designated caregiver as indicated during the transplant process. * Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer * Ability to comprehend and speak English as the CARE app is only available in English Patient Exclusion Criteria: * Caregivers of patients undergoing HCT for benign hematologic conditions * Caregivers with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures

What they're measuring

Caregiver quality of life (QOL) as measured by the Caregiver Oncology Quality of Life (CARGOQOL) questionnaire

Timeframe: up to 60 days post-HCT

Trial details

NCT IDNCT05709912

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01

View on ClinicalTrials.gov More Bone Marrow Transplant Complications trials